PetMed Express Director Tamar Elkeles Receives 49,923-Share Award

What Happened

• Tamar Elkeles, a director of PetMed Express, Inc. (PETS), received a restricted stock award of 49,923 shares on September 17, 2026. The reported acquisition price is $0.00 (grant), so the Form 4 shows $0 total cash paid. This transaction is coded as an award/grant (A).

Key Details

• Transaction date: 2026-09-17; Filing date: 2026-09-21 (filed within the typical two-business-day window for Section 16 filings).
• Price: $0.00 per share (restricted stock grant).
• Shares acquired: 49,923 shares.
• Shares owned after transaction: not specified in the provided report.
• Footnote: The shares are a restricted stock award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan and will vest in full on September 17, 2027, subject to continued service on the Board of Directors.
• No 10b5-1 plan, cashless exercise, tax-withholding, or gift codes reported for this transaction.

Context

• Restricted stock awards are compensation that typically vest over time and are not freely tradable until vesting; the $0 grant price indicates compensation rather than a purchase. Such awards are common for directors and do not by themselves signal a buy or sell decision by the insider.